XERS CapEx to Revenue

Xeris Biopharma Holdings Inc · CapEx to Revenue

XERS logo

XERS CapEx to Revenue

Current (TTM)0.37%
XERS CapEx/Revenue (3.26% → 0.37%)
High-resolution chart · PNG

XERS capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0.2385%
0.4274%
1.3806%
0.4753%
2.1879%
1.8449%
13.8501%
61.2576%
44.9871%
3.2558%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.